Melasma coverage

Melasma coverage is a health insurance benefit that pays for diagnosis or treatment of melasma, which is a skin pigmentation disorder. Most US health insurers exclude melasma treatments such as chemical peels and laser therapy because they classify them as cosmetic procedures, as confirmed by the Insurance Information Database.

Some employer-sponsored plans may cover prescription medications like hydroquinone if prescribed for severe melasma with documented functional impairment. Medicaid rarely covers melasma treatment unless the condition causes significant psychological distress, supported by clinical evidence.

Medicare does not list melasma as a covered indication in its National Coverage Determinations database as of 2024. Insurers require ICD-10 code L81.0 (melasma) on claims to consider any reimbursement request related to this condition.

Prior authorization requirements apply to most non-topical therapies for hyperpigmentation disorders including melasma, according to Aetna’s Clinical Policy Bulletin #0512 (2023). Out-of-pocket costs for uninsured patients seeking laser therapy for melasma average $400–$600 per session based on American Society of Plastic Surgeons data from 2022.

Appeals for denied coverage must include documentation showing medical necessity beyond cosmetic reasons, such as interference with daily activities or mental health impact confirmed by a healthcare provider.